Drawing for ARIES

USPTO serial 87105565

ARIES

Reviewed by CopyMark Law Group

Reg. 5577965Status 710
Filing date
Status date
Registration date
Oct 9, 2018
Examiner
REEVES, APRIL ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ARIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Pickerill

CYNTHIA A MOYER FREDRIKSON & BYRON PA200 S 6TH STREET SUITE 4000MINNEAPOLIS, MN 55402-1424UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in gastroenterology, for colon and digestive system health and regulation, for improving energy levels, for the differentiation of the tissues and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for use in the endoscopic diagnostic evaluation mainly related to gastro-intestinal tract and colon; pharmaceutical compositions for use in endoscopy; diagnostic preparations for medical purposes; pharmaceutical preparations, namely, submucosal injectable compositions for the differentiation of the tissues; liquid pharmaceutical compositions in the form of emulsion for use in endoscopic diagnostic scope procedures; liquid pharmaceutical compositions in the form of micro-emulsion for use in endoscopic diagnostic scope procedures; pharmaceutical product for the treatment of the intestinal infections; pharmaceutical products for treatment of gastroenterological diseases and to facilitate sedation for bronchoscopy and gastroenterological proceduresSECTION 8 - CANCELLED—
010Injection syringes; Endoscopic equipment for medical purposes; Gastroscopes; Catheters; Urethral probe syringes; Tubing for use with catheters; Syringes for medical purposes; Surgical devices and instruments; Probes for medical purposes; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical and surgical catheters; Injection needles; Injection instruments without needles; Disposable syringes; Medical devices for the treatment of gastroenterological diseases and to facilitate sedation for bronchoscopy and gastroenterological procedures; medical diagnostic instruments for the diagnosis and detecting of gastroenterological diseases; excluding goods relating to shockwave therapy devices and/or urological apparatus and devicesSECTION 8 - CANCELLED—
035Retail services through direct solicitation by distributors and salespersons directed to end-users featuring devices for the treatment of gastroenterological diseases, to facilitate sedation for bronchoscopy and gastroenterological procedures and for the diagnosis and detecting of gastroenterological diseases, all of the aforementioned services excluding services relating to shockwave therapy devices and/or urological apparatus and devices; Retail services through direct solicitation by distributors and salespersons directed to end-users featuring pharmaceutical preparations; Wholesale services through direct solicitation by distributors and salespersons directed to end-users featuring pharmaceutical preparations; Online retail services through direct solicitation by distributors directed to end-users featuring pharmaceutical preparationsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 25, 2025C8..CANCELLED SEC. 8 (6-YR)—
Oct 9, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 24, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 24, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 4, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 22, 2018JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
May 22, 2018PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
May 22, 2018APETASSIGNED TO PETITION STAFF—
May 14, 2018ISPOWITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST—
May 8, 2018PDCBPETITION TO DIRECTOR - CHANGE BASIS - RECEIVED—
May 8, 2018TPDRTEAS PETITION TO DIRECTOR RECEIVED—
May 2, 2018TMBNTTAB RELEASE CASE TO TRADEMARKS—
May 2, 2018OP.TOPPOSITION TERMINATED NO. 999999—
May 2, 2018OP.DOPPOSITION DISMISSED NO. 999999—
Dec 21, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 26, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 27, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 19, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 19, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
May 19, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2016DOCKASSIGNED TO EXAMINER—
Jul 22, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance